Analysts Set Merit Medical Systems, Inc. (NASDAQ:MMSI) Price Target at $101.25

Merit Medical Systems, Inc. (NASDAQ:MMSI) has been given an average recommendation of “Moderate Buy” by the ten ratings firms that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $100.1250.

A number of equities research analysts have commented on the stock. Wells Fargo & Company cut shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $95.00 to $78.00 in a research note on Thursday, February 26th. BTIG Research started coverage on shares of Merit Medical Systems in a research report on Friday, February 6th. They set a “buy” rating and a $107.00 price objective on the stock. Piper Sandler reduced their price objective on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Canaccord Genuity Group reduced their price objective on shares of Merit Medical Systems from $99.00 to $90.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research report on Friday, March 27th.

Merit Medical Systems Price Performance

NASDAQ MMSI opened at $67.40 on Friday. Merit Medical Systems has a 12 month low of $66.34 and a 12 month high of $100.19. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 31.79, a PEG ratio of 1.95 and a beta of 0.64. The company’s 50 day moving average is $74.83 and its two-hundred day moving average is $81.36. The company has a current ratio of 4.34, a quick ratio of 2.95 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The company had revenue of $393.94 million for the quarter, compared to analysts’ expectations of $390.77 million. During the same quarter last year, the business earned $0.93 EPS. The firm’s revenue was up 10.9% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, research analysts anticipate that Merit Medical Systems will post 3.37 earnings per share for the current year.

Institutional Investors Weigh In On Merit Medical Systems

Several institutional investors and hedge funds have recently modified their holdings of MMSI. AQR Capital Management LLC raised its position in shares of Merit Medical Systems by 7.3% during the first quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock valued at $1,730,000 after buying an additional 1,114 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Merit Medical Systems by 16.9% during the first quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock valued at $76,039,000 after buying an additional 103,878 shares during the last quarter. Russell Investments Group Ltd. raised its position in shares of Merit Medical Systems by 26.8% during the second quarter. Russell Investments Group Ltd. now owns 50,730 shares of the medical instruments supplier’s stock valued at $4,742,000 after buying an additional 10,722 shares during the last quarter. Norges Bank bought a new stake in shares of Merit Medical Systems during the second quarter valued at approximately $53,697,000. Finally, New York State Common Retirement Fund raised its position in shares of Merit Medical Systems by 6.2% during the second quarter. New York State Common Retirement Fund now owns 18,880 shares of the medical instruments supplier’s stock valued at $1,765,000 after buying an additional 1,100 shares during the last quarter. Institutional investors own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.